Tomofumi Ishikawa
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec® ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: July 01, 2026
Benzodiazepine exposure during early pregnancy and risk of miscarriage: dose-response, half-life classification, and individual agents.
Journal: Archives of women's mental health
Published: February 18, 2026
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.
Journal: The journal of headache and pain
Published: December 17, 2025
Risk of Major Congenital Malformations Associated With the First-Trimester Exposure to Antipsychotics: A Large Claims Database Study.
Journal: Pharmacology research & perspectives
Published: November 10, 2025
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: September 21, 2025
Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: September 18, 2025
Risk of Major Congenital Malformations Associated With First-Trimester Exposure to Topical Antifungal Medications: A Large Claims Database Study.
Journal: Pharmacoepidemiology and drug safety
Published: June 20, 2025
Association of Quinolone Exposure in the First-Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan.
Journal: Pharmacoepidemiology and drug safety
Published: March 27, 2025
Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: January 23, 2025
Association of first-trimester exposure to Kampo medicines containing Prunus persica kernel with preterm birth and major congenital malformations: a Japanese database study.
Journal: Frontiers in pharmacology
Published: January 18, 2025
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.
Journal: Headache
Published: November 28, 2024
Inclination of antidepressant medication continuation during pregnancy between 2012 and 2023 in Japan: A cohort study.
Journal: Journal of affective disorders
Published: August 07, 2024
Last Updated: 09/26/2026